• Skip to main content

UltimateKratom.com

UltimateKratom.com | Ultimate Kratom Reviews

  • Kratom Strains
  • Safety & Law
  • Buying Guide
  • Wellness
  • About

Last updated October 10, 2026

Does Kratom Show Up on a Drug Test? 10- and 12-Panel Guide

Does kratom show up on a drug test? A 10-panel or 12-panel label alone does not tell you that kratom is being tested, because the test order—not the panel number—sets the substances a laboratory looks for. If the order specifically targets kratom alkaloids such as mitragynine or 7-hydroxymitragynine (7-OH), those compounds can be part of the result, so ask the testing program for its written test menu before making assumptions.

Disclosure: The seller link on this page is an affiliate link. This publication may earn a commission if you buy through it. Your price is the same either way.

10- or 12-panel labelIt does not, by itself, name kratom, mitragynine, or 7-OH as a test target.
What to askAsk whether the order includes mitragynine, 7-OH, or a specific kratom analysis.
Opiate resultKratom is not an opiate; an opiate screen and a kratom-targeted analysis are different questions.
7-OHA test must target 7-OH if that is the compound the program wants measured.
Federal statusThe DEA says kratom is not controlled under the Controlled Substances Act, while FDA says kratom is not approved for medical use.

What does a 10-panel or 12-panel test tell you about kratom?

It tells you the testing program selected a panel, but it does not give you the full answer about kratom. Panel names are shorthand. Employers, courts, treatment programs, athletic organizations, and other programs can use different laboratory orders and policies under the same broad label.

The useful question is simple: “Does this order test for mitragynine, 7-hydroxymitragynine, or kratom?” Ask the collection site, program contact, or laboratory before the test. If the answer matters to employment, probation, treatment, or another formal requirement, ask for the policy in writing and read the section on substances that are prohibited even when they are not part of a routine panel.

This is also why a list found online cannot settle your own situation. A urine, blood, saliva, or hair sample is only as relevant to kratom as the laboratory method and order behind it. CDC’s report on overdose deaths notes that postmortem toxicology protocols varied among and within states, and that kratom identification is method-dependent. That is a useful reminder that the sample type is not the whole story. Read the CDC report for how kratom was identified in that specific public-health analysis.

Can kratom make you fail a drug test?

Yes, a result can create a problem when a program orders a kratom-specific analysis or when its written rules prohibit kratom, mitragynine, 7-OH, or psychoactive substances more broadly. A test result and a program decision are related but separate things: the laboratory reports what its method measures, while the program applies its own policy.

If you are being tested for work, school, court supervision, athletics, treatment, or another structured program, get clear answers before the collection date:

  • Which substances does the laboratory order name?
  • Does it list mitragynine, 7-OH, kratom, or an expanded toxicology panel?
  • What happens after an unexpected screening result?
  • Is confirmatory testing part of the program’s process?
  • Does the written policy restrict substances beyond the laboratory panel?

Those questions are about understanding the rules, not trying to work around them. They also give you a useful paper trail if the program asks you to explain a product or ingredient.

Does kratom show up as an opiate?

No, kratom is not an opiate. The CDC explicitly described kratom as not being an opioid in its 2019 analysis, even while noting that mitragynine can produce some opioid-like effects. That distinction matters when you read a test order: an opiate screen is not automatically a mitragynine or 7-OH analysis.

Kratom’s two most discussed alkaloids are mitragynine and 7-OH. NIDA says both activate mu-opioid receptors, which are structures on nerve cells, but their effects only partly compare with opioids such as heroin or oxycodone. Receptor activity does not turn kratom into an opiate screen target. If a program wants a kratom answer, it needs a method that addresses the kratom compounds it is asking about.

Does 7-OH show up on a drug test?

7-OH can be part of a result when the test is designed to target it. Do not assume that a routine panel becomes a 7-OH test because it includes an opiate category. Ask whether the order names 7-OH separately and whether it also includes mitragynine.

The distinction is especially important because 7-OH is not simply another name for whole-leaf kratom. FDA says 7-OH occurs naturally in kratom leaves as a minor constituent, at less than 2% of the leaf’s total alkaloid content. FDA also says products with concentrated 7-OH added as an ingredient, including tablets, gummies, drink mixes, and shots, are a separate concern. In 2025, FDA said it recommended scheduling certain 7-OH products, issued warning letters to firms distributing them, and worked with the U.S. Marshals Service on the seizure of approximately 73,000 units of concentrated 7-OH products from three Missouri firms. See FDA’s 7-OH consumer update and its 2025 seizure announcement for the agency’s description of those actions.

Will kratom give you a false positive?

A false positive means an initial result indicates a substance that a more specific follow-up does not support. The practical move is not to guess from a product name, format, or strain label. Ask the program how it handles an unexpected result, whether it uses confirmation, and what information it wants from you under its rules.

Keep the question focused. A laboratory may have a result for a named target, while a program may also have its own reporting and review process. If you have an unexpected result, follow the program’s stated process and provide accurate information when it asks for product details.

What is the hardest drug test to pass?

There is no single hardest test. The test that matters is the one that specifically measures the substance at issue and is tied to rules that affect you. A broad panel, a custom laboratory order, and a forensic toxicology analysis can answer different questions. The collection method alone does not tell you whether kratom compounds are included.

Do not let a dramatic claim about a “hard” test distract from the one fact you can confirm: the named analytes on your own order. For kratom, the names to ask about are mitragynine and 7-OH.

Do employer drug tests test for kratom?

Some employer programs may use routine panels, while others may order expanded or custom testing. The employer’s policy and the laboratory order decide the question for you. Ask the employer’s testing contact or the collection provider what the order includes; do not rely on the panel number alone.

State and local law can matter as well. The DEA’s October 2025 fact sheet says kratom is not a controlled substance or listed chemical under the federal Controlled Substances Act, and calls it a drug of concern. The same fact sheet says kratom has no legitimate medical use in the United States. Laws still differ by state, and some states and cities ban or restrict kratom or its alkaloids; check the current law where you live rather than treating federal status as a local answer.

What do FDA, DEA, NIDA, NCCIH, and CDC say about kratom?

FDA has not approved kratom or its compounds for any medical use and has warned consumers about kratom. FDA says kratom is not lawfully marketed in the United States as a drug product, dietary supplement, or food additive in conventional food, and warns of serious adverse events including liver toxicity, seizures, and substance use disorder. FDA also says its 7-OH actions concern products containing added or enhanced concentrations of 7-OH, not the trace amount it describes in natural leaf. FDA’s full position appears on its kratom page.

The DEA’s October 2025 fact sheet says kratom is not federally scheduled in its terms, is a drug of concern, and has no legitimate medical use in the United States. DEA reports that America’s Poison Centers’ 2023 annual report counted 1,489 kratom case mentions, 880 single exposures, 671 cases involving treatment in a health-care facility, and 5 deaths. DEA also reports that FDA’s Adverse Event Reporting System recorded kratom as co-involved in 1,486 cases from 2008 through 2025, including 1,387 classified as serious and 715 involving death. Those are DEA-reported figures, not a conclusion that kratom alone caused each event.

NIDA says kratom can produce opioid- and stimulant-like effects and that research is still developing. NIDA identifies mitragynine and 7-OH as the most studied compounds, says products can vary, and says rare serious effects have been reported. NCCIH likewise says very little research in people has evaluated kratom’s health effects and that it has not been shown safe and effective for any medical use. NCCIH lists reported mild effects such as nausea, constipation, dizziness, and drowsiness, along with rarer serious effects including seizures, high blood pressure, and liver problems. CDC reported that kratom was detected in 152 of 27,338 overdose deaths recorded in its 27-state analysis from July 2016 through December 2017; multiple substances were detected in almost all of those deaths.

How should you read a kratom label or lab report?

A label cannot answer your drug-test question by itself, but it can help you understand what product you are considering. Look for the product name, form, ingredients, and a batch or lot identifier that matches any laboratory report. A report is most useful when it is tied to the specific batch rather than a generic brand page.

Super Speciosa is a kratom vendor. Its product pages describe powders, capsules, gummies, tablets, tea bags, extracts, liquids, and shots, and the seller says it provides batch lab reports and uses third-party testing. The seller also says it has shipping restrictions for certain states and localities and offers a 30-day customer satisfaction guarantee. Those are the seller’s statements; this site does not endorse or certify the seller. If you want to check today’s formats, prices, shipping availability, or ordering terms, use the Product Page.

For a closer look at what to look for in a report, see lab-tested kratom. The page on kratom forms can also help you tell powders, capsules, extracts, and other formats apart when reading an order or label.

Can ashwagandha make you fail a drug test?

The answer for your situation comes from the actual test menu and the program’s review process. Ask whether the order includes any specific botanical ingredients or expanded testing, and ask what documentation the program wants if a result is unexpected. Do not assume a supplement name answers the question for a particular laboratory order.

What should you confirm before a test or purchase?

  • Ask whether the test specifically includes mitragynine, 7-OH, or kratom.
  • Read the policy that applies to your job, court program, school, treatment program, or athletic organization.
  • Ask how the program handles unexpected screening results and confirmation.
  • Check current state and local rules before buying or carrying kratom.
  • Match any lab report to the product’s exact batch or lot number.
  • For more on interactions and dependence research, read kratom safety research.

By UltimateKratom.com Research Desk

This article is for general information purposes only and does not constitute medical advice. Consult your doctor or qualified healthcare provider before making changes to your health routine.

Further reading

  1. 7-OH Withdrawal
  2. How Long Does Kratom Stay in Urine? Testing

Written by UltimateKratom.com Research Desk · Categorized: botanical research

  • About
  • Editorial Policy
  • Review Process
  • Corrections
  • Contact
  • Privacy Policy
  • Terms of Use
  • Medical Disclaimer
  • Affiliate Disclosure

Copyright © 2026 · UltimateKratom.com